未破裂旁眼动脉段动脉瘤治疗对视觉功能的影响:系统评价与Meta分析
该系统评价与Meta分析纳入1996至2016年英文文献,评估未破裂旁眼动脉段动脉瘤(UPAs)不同治疗方式对视觉功能的影响。28项研究报告视觉结局,涉及血管内治疗1013例与显微手术691例。视力正常者术后视觉并发症显微手术组高于血管内治疗组(10.8% vs 2.0%,P<0.001);术前视力受损者手术组视觉恢复略优于血管内治疗组(65.2% vs 48.9%,P<0.03)。因数据异质性无法得出确定性结论。
要点
- 视力正常UPAs患者术后视觉并发症率显微手术组10.8%(95%CI 8.5-13.7)高于血管内治疗组2.0%(95%CI 1.2-3.2),P<0.001。
- 术前视力受损者手术组视觉恢复率65.2% vs 血管内治疗组48.9%,P<0.03,手术有适度优势。
- 各血管内治疗方式间视觉并发症无差异;因数据异质性无法得出确定性结论。
核心结论
- 视力正常的UPAs患者中,视觉结局与血管内治疗呈正相关;存在视力损害时,手术在视觉恢复上提供适度优势。
- 由于数据异质性,无法得出确定性结论。
研究设计与样本
- 系统文献分析,检索Ovid Medline和EMBASE数据库,纳入1996年至2016年发表的英文研究报告UPAs治疗结局。
- 采用随机效应Meta分析,28项研究报告视觉结局,涉及血管内治疗1013例和显微手术691例患者。
主要发现
- 视力正常UPAs患者择期修复术后视觉并发症率显微手术组10.8%(95%CI 8.5-13.7)vs 血管内治疗组2.0%(95%CI 1.2-3.2),P<0.001。
- 术前视力受损者手术组视觉恢复率65.2% vs 血管内治疗组48.9%,P<0.03。
- 任何血管内治疗方式间视觉并发症无差异。
- 比较研究Meta分析提示显微手术后视觉结局(ES=0.42;95%CI 0.08-2.09)和临床结局(ES=0.57;95%CI 0.07-4.44)有不良趋势。
- 比较研究Meta分析提示血管内治疗后血管造影复发(ES=2.52;95%CI 0.80-7.90)和再治疗(ES=1.62;95%CI 0.46-5.67)有趋势。
临床怎么用
- 原文未据此给出推荐。
局限性
- 由于数据异质性,无法得出确定性结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Postoperative visual outcomes following repair of unruptured paraclinoid aneurysms (UPAs) are not well defined. We aim to investigate the influence of treatment modality on visual function. METHODS: A systematic literature analysis using the Ovid Medline and EMBASE databases was performed, encompassing English language studies (published between 1996 and 2016) reporting treatment outcomes for UPAs. Rates of visual morbidity (new, permanent postoperative deficit, worsening preoperative deficit); angiographic (occlusion, recurrence, retreatment) and clinical outcomes (death, disability, post-treatment subarachnoid hemorrhage) were recorded. Random effects meta-analysis was performed. RESULTS: Twenty-eight studies reported visual outcomes, with data for 1013 endovascular and 691 microsurgical patients. In patients with normal vision undergoing elective repair of UPAs, rates of postoperative visual morbidity were higher following microsurgical (10.8%; 95% confidence interval [CI] 8.5-13.7) than endovascular (2.0%; 95% CI 1.2-3.2) interventions, P < 0.001. In those presenting with preoperative visual impairment, surgery was associated with a modest advantage in visual recovery compared with endovascular therapies (65.2% vs. 48.9%, P < 0.03). There were no differences in visual morbidity following treatment with any of the endovascular modalities. Meta-analysis of comparative studies suggested a trend toward poor visual (ES = 0.42; 95% CI 0.08-2.09) and clinical outcomes (ES = 0.57; 95% CI 0.07-4.44) following microsurgery and a trend toward angiographic recurrence (ES = 2.52; 95% CI 0.80-7.90) and retreatment (ES = 1.62; 95% CI 0.46-5.67) after endovascular interventions. CONCLUSION: In patients with normal vision undergoing repairs for UPAs, there is a positive correlation between visual outcomes and endovascular treatments. When visual compromise is present, surgery provided modest advantage in visual recovery. However, definitive conclusions were not possible due to data heterogeneity.
引用
- Asaid M, O'Neill AH, Bervini D, et al. Unruptured Paraclinoid Aneurysm Treatment Effects on Visual Function: Systematic Review and Meta-analysis. World Neurosurg. 2017. PMID: 28669879. doi:10.1016/j.wneu.2017.06.135
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。